US Pharma MarketingThe post Takeda unveils secondary endpoint data from Phase III PsO pill trials appeared first on Clinical Trials Arena.
Takeda unveils secondary endpoint data from Phase III PsO pill trials
The key secondary endpoints found Takeda's PsO pill to be beneficial in high-impact areas, including the scalp, palms, and soles. The post Takeda unveils secondary endpoint data from Phase III PsO pill trials appeared first on Clinical Trials Arena .
The key secondary endpoints found Takeda's PsO pill to be beneficial in high-impact areas, including the scalp, palms, and soles.
Source: Clinical Trials Arena